Article Versions Notes

Dadej A, Woźniak-Braszak A, Bilski P, Piotrowska-Kempisty H, Józkowiak M, Geszke-Moritz M, Moritz M, Dadej D, Jelińska A. Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica. Pharmaceutics. 2021; 13(10):1693. https://doi.org/10.3390/pharmaceutics13101693

Dadej, Adrianna, Aneta Woźniak-Braszak, Paweł Bilski, Hanna Piotrowska-Kempisty, Małgorzata Józkowiak, Małgorzata Geszke-Moritz, Michał Moritz, Daniela Dadej, and Anna Jelińska. 2021. "Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica" Pharmaceutics 13, no. 10: 1693. https://doi.org/10.3390/pharmaceutics13101693

Dadej, A., Woźniak-Braszak, A., Bilski, P., Piotrowska-Kempisty, H., Józkowiak, M., Geszke-Moritz, M., Moritz, M., Dadej, D., & Jelińska, A. (2021). Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica. Pharmaceutics, 13(10), 1693. https://doi.org/10.3390/pharmaceutics13101693